BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 17591366)

  • 21. Oestrogen receptors alpha and beta differ in normal human breast and breast carcinomas.
    Shaw JA; Udokang K; Mosquera JM; Chauhan H; Jones JL; Walker RA
    J Pathol; 2002 Dec; 198(4):450-7. PubMed ID: 12434414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of HER-2/neu, ER and PCNA expression in premenopausal and postmenopausal patients with breast carcinoma.
    Zheng W; Zheng J; Ma L; Meng F; Huang L; Ma D
    APMIS; 2005 Mar; 113(3):175-81. PubMed ID: 15799760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
    Rakha EA; El-Sayed ME; Green AR; Paish EC; Powe DG; Gee J; Nicholson RI; Lee AH; Robertson JF; Ellis IO
    J Clin Oncol; 2007 Oct; 25(30):4772-8. PubMed ID: 17876012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of estrogen receptor alpha and beta and progesterone receptor expression and correlation with clinicopathologic factors and proliferative marker Ki-67 in breast cancers.
    Rosa FE; Caldeira JR; Felipes J; Bertonha FB; Quevedo FC; Domingues MA; Moraes Neto FA; Rogatto SR
    Hum Pathol; 2008 May; 39(5):720-30. PubMed ID: 18234277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between oral contraceptive therapy and estrogen receptor status in patients with breast cancer.
    Lumachi F; Ermani M; Marino F; Di Cristofaro L; Tombolan V; Brunello A; Roma A; Basso U
    Anticancer Res; 2008; 28(1B):491-3. PubMed ID: 18383890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical staining of estrogen and progesterone receptors: aspects for evaluating positivity and defining the cutpoints.
    Jalava P; Kuopio T; Huovinen R; Laine J; Collan Y
    Anticancer Res; 2005; 25(3c):2535-42. PubMed ID: 16080489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased progesterone receptor expression in benign epithelium of BRCA1-related breast cancers.
    King TA; Gemignani ML; Li W; Giri DD; Panageas KS; Bogomolniy F; Arroyo C; Olvera N; Robson ME; Offit K; Borgen PI; Boyd J
    Cancer Res; 2004 Aug; 64(15):5051-3. PubMed ID: 15289302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of cytoplasmic and nuclear estrogen receptors and progesterone receptors in human breast cancer.
    Romić-Stojković R; Gamulin S
    Cancer Res; 1980 Dec; 40(12):4821-5. PubMed ID: 7438115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of ERalpha and ERbeta in lobular carcinoma in situ.
    Middleton LP; Perkins GH; Tucker SL; Sahin AA; Singletary SE
    Histopathology; 2007 Jun; 50(7):875-80. PubMed ID: 17543077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor.
    Suzuki T; Miki Y; Moriya T; Shimada N; Ishida T; Hirakawa H; Ohuchi N; Sasano H
    Cancer Res; 2004 Jul; 64(13):4670-6. PubMed ID: 15231680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status.
    Travaglini L; Vian L; Billi M; Grignani F; Nervi C
    Int J Biochem Cell Biol; 2009 Jan; 41(1):225-34. PubMed ID: 18789398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.
    Viale G; Regan MM; Maiorano E; Mastropasqua MG; Dell'Orto P; Rasmussen BB; Raffoul J; Neven P; Orosz Z; Braye S; Ohlschlegel C; Thürlimann B; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
    J Clin Oncol; 2007 Sep; 25(25):3846-52. PubMed ID: 17679725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of pre- and postmenopausal use of exogenous hormones on receptor content in normal human breast tissue: a randomized study.
    Hallberg G; Persson I; Naessén T; Magnusson C
    Gynecol Endocrinol; 2008 Aug; 24(8):475-80. PubMed ID: 18850387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.
    Marot D; Bieche I; Aumas C; Esselin S; Bouquet C; Vacher S; Lazennec G; Perricaudet M; Kuttenn F; Lidereau R; de Roux N
    Endocr Relat Cancer; 2007 Sep; 14(3):691-702. PubMed ID: 17914099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dna synthesis and expression of steroid receptors in cells of human breast carcinoma].
    Simone G; Mangia A; Petroni S; Marzullo F; Paradiso A; Schittulli F
    Pathologica; 1996 Apr; 88(2):111-6. PubMed ID: 8927445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical detection of estrogen and progesterone receptors performed with an antigen-retrieval technique on methacarn-fixed paraffin-embedded breast cancer tissues.
    Oyaizu T; Arita S; Hatano T; Tsubura A
    J Surg Res; 1996 Jan; 60(1):69-73. PubMed ID: 8592434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of insulin-like growth factor-I receptor, estrogen receptor alpha, Bcl-2 and Bax proteins in human breast cancer.
    Koda M; Przystupa W; Jarzabek K; Wincewicz A; Kanczuga-Koda L; Tomaszewski J; Sulkowska M; Wolczynski S; Sulkowski S
    Oncol Rep; 2005 Jul; 14(1):93-8. PubMed ID: 15944774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The normal breast epithelium of women with breast cancer displays an aberrant response to estradiol.
    Khan SA; Sachdeva A; Naim S; Meguid MM; Marx W; Simon H; Halverson JD; Numann PJ
    Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):867-72. PubMed ID: 10548314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of prostate apoptosis response (Par-4) is associated with progesterone receptor in breast cancer.
    Zapata-Benavides P; Méndez-Vázquez JL; González-Rocha TR; Zamora-Avila DE; Franco-Molina MA; Garza-Garza R; Rodriguez-Padilla C
    Arch Med Res; 2009 Oct; 40(7):595-9. PubMed ID: 20082875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
    Tezel GG; Uner A; Yildiz I; Guler G; Takahashi M
    Pathol Res Pract; 2009; 205(6):403-8. PubMed ID: 19232840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.